In SSc and SLE alike, activation of IRFs 4, -5, -7, -8 [146] is considered a risk factor and similar to STAT4, generates increased levels of IFN-I in the plasma of SSc and SLE patients [143,144,147]. This evidence concerns the gene STAT4 and systemic sclerosis.